Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass

Obesity Surgery

Volumn 22, Issue 9, 2012, Pages 1473-1480

  Simonen, M ^a   Dali Youcef, N ^b   Kaminska, D ^c   Venesmaa, S ^a   Kakela P ^a   Paakkonen M ^a   Hallikainen, M ^c   Kolehmainen, M ^c   Uusitupa, M ^c   Moilanen, L ^a   Laakso, M ^a   Gylling, H ^c   Patti, M E ^d   Auwerx, J ^e   Pihlajamäki, Jussi ^a,c  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d HARVARD MEDICAL SCHOOL   (United States)

^e EPFL   (Switzerland)

Author keywords

Bile acids; CYP27A1; DIO2; Glucose and lipid oxidation; Obesity surgery

Indexed keywords

BILE ACID CONJUGATE; CHOLESTANETRIOL 26 MONOOXYGENASE; CHOLESTEROL 7ALPHA MONOOXYGENASE; MESSENGER RNA; TAUROCHENODEOXYCHOLIC ACID; TAUROCHOLIC ACID; TAURODEOXYCHOLIC ACID; TAUROLITHOCHOLIC ACID; TAUROURSODEOXYCHOLIC ACID;

ADIPOSE TISSUE; ADULT; ARTICLE; BILE ACID BLOOD LEVEL; BILE ACID METABOLISM; CALORIMETRY; CLINICAL ARTICLE; CYP27A1 GENE; CYP7A1 GENE; DIO2 GENE; ENERGY EXPENDITURE; ENERGY METABOLISM; FEMALE; FOLLOW UP; GENE; GLUCOSE OXIDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIPID OXIDATION; LONGITUDINAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY QUOTIENT; ROUX Y ANASTOMOSIS; STOMACH BYPASS; TANDEM MASS SPECTROMETRY;

ADIPOSE TISSUE; BILE ACIDS AND SALTS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; ENERGY METABOLISM; FEMALE; FINLAND; GASTRIC BYPASS; GLUCOSE; HUMANS; LIPID METABOLISM; LIVER; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY, MORBID; TREATMENT OUTCOME;

EID: 84866140915     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-012-0673-5     Document Type: Article

References (32)

1. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-37. (Pubitemid 39346675)
2. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-93. (Pubitemid 39665322)
3. Weber M, Muller MK, Bucher T, et al. Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity. Ann Surg. 2004;240:975-82. discussion 982-3. (Pubitemid 39602125)
4. Nguyen NT, Slone JA, Nguyen XM, et al. A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg. 2009;250:631-41.
5. Thaler JP, Cummings DE. Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009;150:2518-25.
6. le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006;243:108-14. (Pubitemid 43054062)
7. le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007;246:780-5. (Pubitemid 350035654)
8. Korner J, Bessler M, Inabnet W, et al. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis. 2007;3:597-601. (Pubitemid 350091417)
9. Thomas C, Pellicciari R, Pruzanski M, et al. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov. 2008;7:678-93.
10. Hofmann AF, Hagey LR. Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell Mol Life Sci. 2008;65:2461-83.
11. Lefebvre P, Cariou B, Lien F, et al. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev. 2009;89:147-91.
12. Bilz S, Samuel V, Morino K, et al. Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters. Am J Physiol Endocrinol Metab. 2006;290:E716-22.
13. Cariou B, van Harmelen K, Duran-Sandoval D, et al. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J Biol Chem. 2006;281:11039-49. (Pubitemid 43855527)
14. Watanabe M, Houten SM, Wang L, et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest. 2004;113:1408-18. (Pubitemid 39071696)
15. Ma K, Saha PK, Chan L, et al. Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest. 2006;116:1102-9.
16. Maruyama T, Miyamoto Y, Nakamura T, et al. Identification of membrane-type receptor for bile acids (M-BAR). Biochem Biophys Res Commun. 2002;298:714-9. (Pubitemid 35356798)
17. Kawamata Y, Fujii R, Hosoya M, et al. A G protein-coupled receptor responsive to bile acids. J Biol Chem. 2003;278:9435-40. (Pubitemid 36800434)
18. Watanabe M, Houten SM, Mataki C, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439:484-9. (Pubitemid 43152840)
19. Katsuma S, Hirasawa A, Tsujimoto G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun. 2005;329:386-90. (Pubitemid 40255465)
20. Thomas C, Gioiello A, Noriega L, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 2009;10:167-77.
21. Parks DJ, Blanchard SG, Bledsoe RK, et al. Bile acids: natural ligands for an orphan nuclear receptor. Science. 1999;21:1365-8. (Pubitemid 29289664)
22. Patti ME, Houten SM, Bianco AC, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring). 2009;17:1671-7.
23. Pihlajamaki J, Gronlund S, Simonen M, et al. Cholesterol absorption decreases after Roux-en-Y gastric bypass but not after gastric banding. Metabolism. 2010;59:866-72.
24. Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism. 1988;37:287-301. (Pubitemid 18080935)
25. da Rocha EE, Alves VG, da Fonseca RB. Indirect calorimetry: methodology, instruments and clinical application. Curr Opin Clin Nutr Metab Care. 2006;9:247-56. (Pubitemid 44097836)
26. Argmann CA, Houten SM, Champy MF, et al. Lipid and bile acid analysis. Curr Protoc Mol Biol. 2006;29:29B.2.1-29B.2.24.
27. Kohli R, Kirby M, Setchell KD, et al. Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities. Am J Physiol Gastrointest Liver Physiol. 2010;299:652-6.
28. de Castro Cesar M, de Lima Montebelo MI, Rasera Jr I, et al. Effects of Roux-en-Y gastric bypass on resting energy expenditure in women. Obes Surg. 2008;18:1376-80.
29. Bobbioni-Harsch E, Morel P, Huber O, et al. Energy economy hampers body weight loss after gastric bypass. J Clin Endocrinol Metab. 2000;85:4695-700. (Pubitemid 32157654)
30. Nakatani H, Kasama K, Oshiro T, et al. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metabolism. 2009;58:1400-7.
31. Zhao X, Peter A, Fritsche J, et al. Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at? Am J Physiol Endocrinol Metab. 2009;296:E384-93.
32. Angelin B, Bjorkhem I, Einarsson K, et al. Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. J Clin Invest. 1982;70:724-31. (Pubitemid 12038088)